- Financial Times•2 hours ago
A billion-dollar global coalition will create new vaccines to protect the world against emerging viruses that could cause catastrophic epidemics. Bill Gates, one of the coalition's biggest backers through ...
- Bloomberg•2 hours ago
Spurred by the Ebola and Zika epidemics, GlaxoSmithKline Plc, Johnson & Johnson and Sanofi are among drugmakers backing an effort to develop new vaccines that could be deployed swiftly to contain outbreaks ...
- Reuters - UK Focus•13 hours ago
Two decades after they were spurred into action to tackle AIDS in Africa, global drugmakers said on Wednesday they would invest an initial $50 million over three years to fight cancer and other non-communicable diseases in poor countries. Twenty-two companies, including Pfizer (NYSE: PFE - news) , Merck (Jakarta: 28586808.JK - news) , Novartis (IOB: 0QLR.IL - news) , Roche, Sanofi (LSE: 0O59.L - news) and GlaxoSmithKline (Other OTC: GLAXF - news) , will contribute funds and expertise to the project, which is backed by the World Bank. The so-called Access Accelerated initiative was announced at the World Economic Forum in Davos and aims to improve both treatment and prevention.
GSK.L: Summary for GLAXOSMITHKLINE PLC ORD 25P - Yahoo Finance
GlaxoSmithKline plc (GSK.L)
LSE - LSE Delayed price. Currency in GBp
Add to watchlist
|Bid||1,550.00 x 175400|
|Ask||1,580.00 x 417900|
|Day's range||1,552.50 - 1,567.00|
|52-week range||1,314.26 - 1,745.56|
|PE ratio (TTM)||255.82|
|Dividend & yield||0.93 (4.73%)|
|1y target est||N/A|